Casa Sollievo della Sofferenza, San Giovanni Rotondo Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2005
NCT00374101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Division of Gastroenterology, Casa Sollievo della Sofferenza, San Giovanni Rotondo, ITALY

Active Ingredients

Drugs in Phase 3 Trials (2)

omeprazole (prilosec) (1 trial)

pantoprazole (protonix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastrointestinal Hemorrhage (Phase 3)

Hemorrhage (Phase 3)

Peptic Ulcer (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2